Advertisement

Topics

Puma Biotechnology Reports Third Quarter 2017 Financial Results

16:07 EST 9 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Results include the initial sales of NERLYNX® in the U.S. Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced financial results for the third quarter and nine months ended September 30, 20...

Other Sources for this Article

Puma Biotechnology, Inc.
Alan H. Auerbach or Mariann Ohanesian, +1 424-248-6500
info@pumabiotechnology.com
ir@pumabiotechnology.com
or
Russo Partners
David Schull or Amiad Finkelthal, +1 212-845-4200
david.schull@russopartnersllc.com
amiad.finkelthal@russopartnersllc.com

NEXT ARTICLE

More From BioPortfolio on "Puma Biotechnology Reports Third Quarter 2017 Financial Results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...